City
Epaper

J&J reaches $1B Covid-19 vax deal with US

By IANS | Updated: August 6, 2020 11:55 IST

New York, Aug 6 Global healthcare company Johnson & Johnson has reached a $1 billion deal with the ...

Open in App

New York, Aug 6 Global healthcare company Johnson & Johnson has reached a $1 billion deal with the US government for manufacturing and delivery of 100 million doses of its Covid-19 vaccine that is being tested.

The US government may also purchase an additional 200 million doses of the vaccine, Ad26.COV2.S, under a subsequent agreement, the company said on Wednesday.

"We greatly appreciate the US government's confidence in, and support for, our R&D platform and efforts and the scalability of our vaccine technology," Paul Stoffels, Chief Scientific Officer at Johnson & Johnson, said in a statement.

"We are scaling up production in the US and worldwide to deliver a SARS-CoV-2 vaccine for emergency use," Stoffels said.

Based on the positive preclinical data recently published in the peer reviewed journal Nature, early stage clinical trial of the vaccine candidate, Ad26.COV2.S, is underway in healthy volunteers in the US and Belgium.

The company is evaluating one- and two-dose regimens, in its clinical programme.

Johnson & Johnson said it aims to meet its goal to supply more than one billion doses globally through the course of 2021, provided the vaccine is safe and effective.

J&J's Covid-19 vaccine programme is leveraging Janssen Pharmaceutical Companies' (Janssen) adenovector technology that provides the ability to rapidly develop new vaccine candidates.

It is planning to start a Phase-3 clinical trial of its Covid-19 vaccine ahead of its original schedule, potentially in late September.

( With inputs from IANS )

Tags: Johnson & JohnsonJohnson & johnsonPaul stoffels
Open in App

Related Stories

HealthJohnson & Johnson asked to pay $18.8 million to man who got cancer from baby powder

HealthEli Lilly's drug to lead obesity, diabetes treatment: Report

HealthJohnson and Johnson offers 8.9 billion dollar settlement of talcum cancer claims

BusinessJohnson & Johnson offers USD 8.9 bln to settle 'talc caused cancer' lawsuits

NationalI had major side effects from 2nd Covid booster shot: Elon Musk

Health Realted Stories

HealthUS launches next-generation universal vaccine platform for pandemic-prone viruses

HealthSocial pension: Tripura govt sets up new help desk for cancer patients

HealthTN school reopening decision will depend on heatwave conditions: Minister

HealthGlobal recognition of Yoga testament to India’s rich cultural heritage: Ayush Minister

HealthGujarat beneficiaries of Ayushman Bharat gettting life-saving medical treatments without financial strain